| Filed | Form | Description | |
|---|---|---|---|
| 7/14/25 | DEF 14A | DEF 14A | → |
| 7/2/25 | PRE 14A | PRE 14A | → |
| 5/19/25 | DEFA14A | DEFA14A | → |
| 4/22/25 | DEFA14A | DEFA14A | → |
| 4/22/25 | DEF 14A | DEF 14A | → |
| 5/21/24 | DEFA14A | DEFA14A | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 2/27/26 | 4 | 4 | → |
| 2/24/26 | 4 | 4 | → |
| 2/24/26 | 4 | 4 | → |
| 8/5/25 | 4 | 4 | → |
| 8/5/25 | 4 | 4 | → |
| 8/5/25 | 4 | 4 | → |
| ↓ | |||
Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing.